| #39 |
Caprice L. Gray |
E Ink Holdings |
1 |
| #39 |
Christian R. Shelton |
MIT |
1 |
| #39 |
Thomas Hoock |
Vertex Pharmaceuticals Incorporated |
1 |
| #39 |
Joseph B. Mandeville |
The General Hospital |
1 |
| #39 |
Eric S. Lightcap |
Millennium Pharmaceuticals |
1 |
| #39 |
Raymond G. Jussaume |
Tyco Electronics Co. |
1 |
| #39 |
Torkel Engeness |
Omniguide Communications |
1 |
| #39 |
Chun-Ming Niu |
Hyperion Catalysis International |
1 |
| #39 |
Ytshak Avrahami |
MIT |
1 |
| #39 |
Chad C. Huval |
Genzyme |
1 |
| #39 |
Ganesh Venkataraman |
MIT |
1 |
| #39 |
Ralf Birken |
Witten Technologies |
1 |
| #39 |
Joseph Lobacki |
Finch Therapeutics Holdings |
1 |
| #39 |
Sarah D. Oeltjen |
Tecan Trading Ag |
1 |
| #39 |
Dharanipal Doppalapudi |
Boston Microsystems |
1 |
| #39 |
Laura L. Chapman |
Tecan Trading Ag |
1 |
| #39 |
Qifeng Xue |
Aclara Biosciences |
1 |
| #39 |
Corinne Reimer |
Mercian |
1 |
| #39 |
Robert Larsen |
Draper Laboratory |
1 |
| #39 |
Terence Sean Sullivan |
Rangecast Technologies |
1 |
| #39 |
Bikram Yonjan |
Shaser |
1 |
| #39 |
Thomas Frey |
Robert Bosch Gmbh |
1 |
| #39 |
Sabrina Anne Sequeira |
GE |
1 |
| #39 |
Ben S. Hayden |
Google |
1 |
| #39 |
David Walter Lewinnek |
Teradyne |
1 |
| #39 |
Simon Jones |
Genetics Institute |
1 |
| #39 |
Elisabeth A. Raleigh |
New England Biolabs |
1 |
| #39 |
Craig Schmidt |
I2 Technologies Us |
1 |
| #39 |
Martin T. Moore |
IBM |
1 |
| #39 |
Joev Dubach |
Dragon Systems |
1 |
| #39 |
Herman Van Vlijmen |
Biogen Idec Ma |
1 |
| #39 |
Stephen McDevitt |
The Gillette Company |
1 |
| #39 |
Aiqi Fang |
MIT |
1 |
| #39 |
Christopher Travis Turner |
Neurometrix |
1 |
| #39 |
John E. Minardi |
St. Clair Intellectual Property Consultants |
1 |
| #39 |
Gordon Siek |
Reference Diagnostics |
1 |
| #39 |
Tom Devlin |
Smiths Industries Medical Systems |
1 |
| #39 |
Etienne Barnard |
Speechworks International |
1 |
| #39 |
Costa G. Chitouras |
— |
1 |
| #39 |
Andre Morkel |
— |
1 |
| #39 |
Candeloro DiCecca |
Koch Membrane Systems |
1 |
| #39 |
Michael Voronkov |
Signum Biosciences |
1 |
| #39 |
Mark C. Matthews |
Acme United |
1 |
| #39 |
Doug Naegele |
Vertex Pharmaceuticals Incorporated |
1 |
| #39 |
Gregory D. Allen |
3M |
1 |
| #39 |
Antonios Giannakopoulos |
MIT |
1 |
| #39 |
Harvey Koselka |
Vision Robotics |
1 |
| #39 |
David Cleary |
General Motors |
1 |
| #39 |
Michael Switkes |
MIT |
1 |
| #39 |
Pablo Jimenez |
Human Genome Sciences |
1 |